Bobos P, Nazari G, Szekeres M, Lalone EA, Ferreira L, MacDermid JC The effectiveness of joint-protection programs on pain, hand function, and grip strength levels in patients with hand arthritis: A systematic review and meta-analysis. J Hand Ther. 2019 Apr-Jun;32(2):194-211. doi: 10.1016/j.jht.2018.09.012. Epub 2018 Dec 23.
Bukhave EB, Huniche L Activity problems in everyday life--patients' perspectives of hand osteoarthritis: "try imagining what it would be like having no hands". Disabil Rehabil. 2014;36(19):1636-43. doi: 10.3109/09638288.2013.863390. Epub 2013 Dec 6.
Fisher AG, Jones KB Assessment of motor and process skills : Volume 1: Development, standardization, and administration manual. 7. ed., Re. Fisher AG, Jones KB, editors. Fort Collins, Colo: Three Star Press; 2012.
Fisher AG, Jones KB Assessment of motor and process skills : Volume 2: User Manual. 7. ed. Fisher AG, Jones KB, editors. Fort Collins, Colo: Three Star Press; 2014.
Fisher AG, Marterella A Powerful practice: a Model for Authentic Occupational Therapy. Fisher AG, Marterella A, editors. Fort Collins, Colorado, USA: CIOTS - Center for innovative OT solutions..; 2019.
GBD 2021 Low Back Pain Collaborators Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 May 22;5(6):e316-e329. doi: 10.1016/S2665-9913(23)00098-X. eCollection 2023 Jun.
Hand C, Law M, McColl MA Occupational therapy interventions for chronic diseases: a scoping review. Am J Occup Ther. 2011 Jul-Aug;65(4):428-36. doi: 10.5014/ajot.2011.002071.
Haugen IK, Englund M, Aliabadi P, Niu J, Clancy M, Kvien TK, Felson DT Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann Rheum Dis. 2011 Sep;70(9):1581-6. doi: 10.1136/ard.2011.150078. Epub 2011 May 27. Erratum In: Ann Rheum Dis. 2018 Oct;77(10):1546.
Lykkegaard J, Møller A and GH Håndartrose blandt +70 årige i Almen Praksis, Denmark. [Hand Osteoarthritis among +70 year olds in General Practice, Denmark] Copenhagen; 2021.
Takata SC, Wade ET, Roll SC Hand therapy interventions, outcomes, and diagnoses evaluated over the last 10 years: A mapping review linking research to practice. J Hand Ther. 2019 Jan-Mar;32(1):1-9. doi: 10.1016/j.jht.2017.05.018. Epub 2017 Jun 21.
Waehrens EE, Bliddal H, Danneskiold-Samsoe B, Lund H, Fisher AG Differences between questionnaire- and interview-based measures of activities of daily living (ADL) ability and their association with observed ADL ability in women with rheumatoid arthritis, knee osteoarthritis, and fibromyalgia. Scand J Rheumatol. 2012 Mar;41(2):95-102. doi: 10.3109/03009742.2011.632380. Epub 2012 Jan 30.
Waehrens EE, Nielsen KT ADL-Interview (ADL-I). Klinisk version 1.0 - Introduktion, ADL-I og administration [Clinical version 1.0 - Introduction, ADL-I, and administration]. Copenhagen; 2020.
Waehrens EE Measuring quality of occupational performance based on self-report and observation : development and validation of instruments to evaluate ADL task performance. Sweden, Umeå; 2010.
Feasibility of a Cross-sectorial Management Program in Hand Osteoarthritis
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
